Torrent Pharmaceuticals Financial Statements
Quarterly
Yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 1,937 | 2,134 | 2,137 | 2,108 | 2,131 |
| Expenses | 1,519 | 1,622 | 1,645 | 1,737 | 2,217 |
| EBITDA | 417.89 | 512.00 | 492.00 | 371.00 | -86.00 |
| EBIT | 253.10 | 347.00 | 324.00 | 204.00 | -248.00 |
| Profit Before Tax | 383.26 | 484.00 | 472.00 | 357.00 | -87.00 |
| Net Profit | 323.88 | 330.00 | 316.00 | 249.00 | -118.00 |
| Financial Ratios | |||||
| Operating Profit Margin | 21.58% | 23.99% | 23.02% | 17.60% | -4.04% |
| Net Profit Margin | 16.72% | 15.46% | 14.79% | 11.81% | -5.54% |
| Earning Per Share (Diluted) | 19.16 | 19.53 | 18.63 | 14.75 | 11.67 |
| Dividends Per Share | 15.00 | NA | 25.00 | NA | 8.00 |
